NCT06944145 New Treatment Strategies and Epigenetic Biomarker for Management of Benign Prostatic Hyperplasia Status RECRUITING Phase PHASE2
NCT06601205 Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer. Status COMPLETED Phase PHASE2/PHASE3
NCT05990400 Effectiveness and Safety of Topical Finasteride and Minoxidil Combination Compared to Topical Minoxidil for The Treatment of Male Androgenetic Alopecia Status UNKNOWN Phase PHASE2/PHASE3
NCT04848181 The Effect of Pre-operative Use of Finasteride Versus Cyproterone Acetate on Blood Loss With Transurethral Resection of Prostate Status COMPLETED Phase EARLY_PHASE1
NCT03004469 Study to Evaluate the Efficacy and Safety of P-3074 Topical Solution in the Treatment of Androgenetic Alopecia Status COMPLETED Phase PHASE3
NCT02781311 A Safety and Efficacy Study of Setipiprant Tablets in Androgenetic Alopecia in Males Status COMPLETED Phase PHASE2
NCT02548117 H-36731: Finasteride in Management of Elevated Red Blood Cells Status WITHDRAWN Phase PHASE3
NCT02248701 Testosterone Plus Finasteride Treatment After Spinal Cord Injury Status TERMINATED Phase PHASE2
NCT02244229 Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients Status COMPLETED Phase PHASE4
NCT01736033 Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients Status UNKNOWN Phase PHASE4
NCT01534351 Comparison of Finasteride and Tamsulosin for Treatment of Benign Prostatic Hyperplasia (BPH) (MK-0906A-149 AM2) Status TERMINATED Phase PHASE3
NCT01342367 Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer Status ACTIVE_NOT_RECRUITING Phase NA
NCT01296672 3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer Status COMPLETED Phase PHASE4
NCT01264302 Bioequivalence Study of Two Finasteride 5 mg Tablet Formulations Under Non-Fasting Conditions Status COMPLETED Phase PHASE1
NCT01264289 Bioequivalence Study of Finasteride 5 mg Tablet Formulations Under Fasting Conditions Status COMPLETED Phase PHASE1
NCT01227993 Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy Status COMPLETED Phase PHASE1/PHASE2